Trade GANX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Gain Therapeutics, Inc. (GANX) is trading at US$1.75, up 2.34% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$87.51M. Over the past 52 weeks, GANX has traded between US$1.53 and US$4.34. On Syfe you can trade GANX with $0 commission and add it to your watchlist.
| Previous close | US$1.71 |
|---|---|
| Market cap | US$87.51M |
| 52-week range | US$1.53 – US$4.34 |
| Volume | 213.22K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Gain Therapeutics, Inc.
Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.
Year: 2021
Gain Therapeutics Names Joanne Taylor Chief Scientific Officer, Terenzio Ignoni as COO
Jul 16, 12:21 PM · MT Newswires
Gain Therapeutics Gets US FDA Approval to Advance GT-02287 Into Phase 2 Study for Parkinson's Disease
Jun 29, 8:36 PM · MT Newswires
Gain Therapeutics, Inc. (GANX) stock is trading at US$1.75, +2.34% from the previous close of US$1.71.
The market cap for Gain Therapeutics, Inc. (GANX) stock is approximately US$87.51M.
The 52-week high for Gain Therapeutics, Inc. (GANX) stock is US$4.34.
The 52-week low for Gain Therapeutics, Inc. (GANX) stock is US$1.53.
Gain Therapeutics, Inc. (GANX) does not currently pay a dividend.
Stay on top of GANX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
